title: Saliva production and surface tension: influences on patency of the passive upper airway.
abstract: Pharyngeal patency is influenced by the surface tension (gamma) of the upper airway lining liquid (UAL), of which saliva is a major component. We investigated the influences of saliva production on gamma of the UAL, and upper airway re-opening and closing pressures. In 10 supine, male, anaesthetized, tracheostomised, mechanically ventilated New Zealand White rabbits, we measured re-opening and closing of the passive isolated upper airway at baseline and following graded (cumulative) doses of methacholine or atropine. Upper airway liquid volume index (UALVI) was assessed using a standardized suction procedure (secretion weight obtained per second) expressed as the natural logarithm (LnUALVI). The gamma of UAL samples were measured using the 'pull-off' force technique. Across all animals, baseline values were: LnUALVI -6.2 (-8.6 to -5.4) median (interquartile range), gamma of UAL 58.9 (56.6-59.9) mN m(-1), re-opening 8.6 (6.9-11.1) cmH(2)O, and closing pressures 3.2 (1.8-5.7) cmH(2)O. LnUALVI increased by approximately 0.17 per microg kg(-1) methacholine and decreased by approximately 0.14 per 100 microg kg(-1) atropine (both P < 0.03, linear mixed effects modelling). Surface tension was unchanged by methacholine but increased by approximately 0.6 mN m(-1) per 100 microg kg(-1) atropine (P < 0.004). When data were analysed across all animals, both re-opening and closing pressures increased as surface tension increased (by approximately 0.4 cmH(2)O mN(-1) and by approximately 0.7 cmH(2)O mN(-1), respectively; both P < 0.05). We conclude that saliva production influences upper airway mechanical properties partly via alterations in gamma of UAL. We speculate that in obstructive sleep apnoea, altered autonomic activity may reduce saliva production and increase surface tension of the upper airway lining liquid, thus increasing the likelihood of upper airway obstruction.
authors.affiliation: Division of Respiratory and Critical Care Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, SAR, China.
authors.forename: J C M
authors.initials: JC
authors.lastname: Lam
authors.forename: K
authors.initials: K
authors.lastname: Kairaitis
authors.forename: M
authors.initials: M
authors.lastname: Verma
authors.forename: J R
authors.initials: JR
authors.lastname: Wheatley
authors.forename: T C
authors.initials: TC
authors.lastname: Amis
mesh_terms: D000818:Animals; D001285:Atropine / Q000494:pharmacology; D006801:Humans; D008297:Male; D016210:Methacholine Chloride / Q000494:pharmacology; D023421:Models, Animal; D010614:Pharynx / Q000502:physiology; D011817:Rabbits; D015656:Respiratory Mechanics; D012143:Respiratory Physiological Phenomena; D012137:Respiratory System / Q000187:drug effects / Q000294:innervation / Q000378:metabolism*; D012463:Saliva / Q000378:metabolism*; D013500:Surface Tension; D014132:Trachea / Q000502:physiology
chemical_list: D016210:Methacholine Chloride; D001285:Atropine